セッション情報

International Session(Oral)

第51回・2013年・京都
International Session(Oral)
International Session 1
International Session 1
開催回
第51回・2013年・京都

Involvement of Jak/STAT Pathway in Esophageal Cancer

演題番号 : ISO1-1

Aysegul Ilhan-mutlu:1,4、Matthias Preusser:1,4、Sebastian Schoppmann:2,4、Peter Birner:3,4

1:Department of Oncology, Medical University of Vienna, Austria、2:Department of Surgery, Medical University of Vienna, Vienna, Austria、3:Department of Pathology, Medical University of Vienna, Austria、4:CCC- Gastroesophageal Tumor Unit, Medical University of Vienna, Austria

Involvement of Jak/STAT Pathway in Esophageal Cancer

Phase II Study of Panitumumab + CPT-11 as 2nd-line Therapy for Esophageal AC

演題番号 : ISO1-2

Michael K Gibson:1、Yang Liu :4、Harry Yoon:2、Arlene Forastiere:3

1:Seidman Cancer Center, University Hospitals Case Medical Center, USA、2:Mayo Clinic, USA、3:Johns Hopkins University, USA、4:University of Pittsburgh, USA

Phase II Study of Panitumumab + CPT-11 as 2nd-line Therapy for Esophageal AC

Combined APC and Bougienage via endoscopy for treatment of anastomotic-stenosis

演題番号 : ISO1-3

Rui Nuo Jia:1、Kaili Ding:1、Xiaoshan Feng:1、Gang Liu:1、Tanyou Shan:1、Guoqiang Kong:1、Xinshuai Wang:1、Jiachun Sun:1、Xiaozhi Yuan:1、Ruina Yang:1、Dan Zhou:1、Lidong Wang:1、Shegan Gao:1

1:Cancer Institute, First Affiliated Hospital of Henan Science & Technology University, China

Combined APC and Bougienage via endoscopy for treatment of anastomotic-stenosis

Doc plus FOLFOX4 as adjuvant chemotherapy for stage Ib-IV (M0) gastric cancer

演題番号 : ISO1-4

Chunxia Du:1、Jinwan Wang:1、Aiping Zhou:1、Jing Huang:1、Honggang Zhang:1

1:Med Oncol Dept, CICAMS, China

Doc plus FOLFOX4 as adjuvant chemotherapy for stage Ib-IV (M0) gastric cancer

RECTAL CANCER in Nepal -EXPERIENCE WITH 200 CASES

演題番号 : ISO1-5

Prakash Raj Neupane:1

1:Surgical Oncology, Bhaktapur Cancer Hospital, Nepal

RECTAL CANCER in Nepal -EXPERIENCE WITH 200 CASES

PEPT1 is a valuable biomarker for predicting efficacy of ALA-PDT in PC

演題番号 : ISO1-6

Yang Liu:1、Shun-ichiro Ogura:2、Yoshio Endo:3、Emel Canbay :1、Haruaki Ishibashi :1、Yutaka Yonemura :1

1:NPO Organization to Support Peritoneal Dissemination Treatment, Japan、2:Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Japan、3:Central Research Resource Branch, Cancer Research Institute, Kanazawa University, Japan

PEPT1 is a valuable biomarker for predicting efficacy of ALA-PDT in PC

Chemotherapy and liver transplantation for advanced hepatoblastoma

演題番号 : ISO1-7

Ryuhei Tanaka:1、Atsuko Watanabe:1、Seisuke Sakamoto:2、Hiriyuki Kanazawa:2、Nobuhiro Tanno:1、Takeshi Komaki:1、Mureo Kasahara:2

1:Pediatric Oncol/Hematol, Int Natl Med Centr, Saitama Med Univ, Japan、2:Transplantation Center, National Center for Child Health and Development , Japan

Chemotherapy and liver transplantation for advanced hepatoblastoma